CompletedPhase 2NCT04996264

Broad-spectrum Rapid Antidote: Varespladib Oral for Snakebite

Studying Snakebite envenomation

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Ophirex, Inc.
Principal Investigator
Matthew Lewin, MD, PhD, MD
Ophirex, Inc.
Intervention
Varespladib Methyl(drug)
Enrollment
95 target
Eligibility
5 years · All sexes
Timeline
20212023

Study locations (16)

Collaborators

Premier Research

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT04996264 on ClinicalTrials.gov

Other trials for Snakebite envenomation

Additional recruiting or active studies for the same condition.

See all trials for Snakebite envenomation

← Back to all trials